Rexall Sundown fourth-quarter sales rise 25%; earnings double.
This article was originally published in The Tan Sheet
Executive Summary
REXALL SUNDOWN FISCAL FOURTH-QUARTER SALES UP 25% to $51.6 mil. on broader distribution of the company's Sundown vitamin line, the firm announced Oct. 10. Income from continuing operations for the three-month period ended Aug. 31 more than doubled (up 108.3%) to $6.5 mil. Rexall reported a net loss of $1.9 mil. in the fourth quarter of fiscal 1995 related to the divestiture of Pennex Labs